| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 1292-1298, Copyright © 1996 by Endocrine Society
ARTICLES |
ED Albrecht, GW Aberdeen, JS Babischkin, JL Tilly and GJ Pepe
Department of Obstetrics/Gynecology, Center for Studies in Reproduction, University of Maryland School of Medicine, Baltimore, 21201, USA.
We have previously shown an estrogen-dependent developmental regulation of placental oxidation of cortisol to cortisone that results in enhanced fetal pituitary ACTH production and the induction of steroidogenic enzymes in and de novo cortisol production by the fetal adrenal in the second half of baboon pregnancy. However, it is not known whether the receptor for ACTH is simultaneously generated at this time in development to provide a mechanism for mediating the tropic action of ACTH on steroidogenesis in the primate fetal adrenal gland. Therefore, in the present study we determined the levels of ACTH receptor messenger RNA (mRNA) and correlated ACTH receptor expression with appearance of the mRNA for delta5-3beta-hydroxysteroid dehydrogenase/isomerase (3betaHSD), the enzyme protein that signals functional maturation of the definitive cortical zone in the baboon fetal adrenal. A baboon ACTH receptor complementary DNA was cloned and hybridized with polyadenylated RNA isolated from baboon (Papio anubis) fetal adrenals obtained in early (days 58-64; RNA from seven baboon fetuses pooled to yield three samples), mid-(days 99-103; RNA from five baboons pooled to yield four samples), and late (days 165-168; RNA of four individual baboon fetuses) gestation (term = 184 days). Expression of the primary 3.4-kilobase ACTH receptor mRNA transcript, determined by Northern blot and expressed as a ratio of beta-actin mRNA, was minimal early in gestation (mean +/- SE, 0.11 +/- 0.05 arbitrary densitometric units). However, fetal adrenal ACTH receptor mRNA levels increased (P < 0.001, by ANOVA) approximately 13-fold to 1.41 +/- 0.16 at midgestation, then declined by 70% (P < 0.001) to 0.41 +/- 0.10 in late gestation. To determine whether the decrease in ACTH receptor expression by the fetal adrenal in the second half of pregnancy reflected programmed cell death, the integrity of genomic DNA was assessed by 32P-labeled DNA gel electrophoresis and in situ DNA end labeling. Because DNA oligonucleosomes and apoptotic DNA strand breaks characteristic of apoptosis were absent in the adrenal glands of fetal baboons, the decline in ACTH receptor mRNA levels in the fetal adrenal did not seem to reflect programmed cell death. Expression of the single 2.0-kilobase mRNA transcript for 3betaHSD, an enzyme localized specifically in the definitive zone of the fetal adrenal, was minimal in early (0.01 +/- 0.00 arbitrary units) and mid- (0.10 +/- 0.01) gestation. However, 3betaHSD mRNA levels were markedly increased late in gestation to a value (1.38 =/- 0.34) approximately 13-fold greater (P < 0.001) than that in midgestation. These findings indicate that there was a biphasic monomodal developmental expression of the ACTH receptor in the baboon fetal adrenal, which contrasted with the progressive increase in adrenal weight, 3betaHSD expression, and de novo cortisol production previously determined. Because the fetal adrenal is comprised mainly of the fetal cortical zone throughout gestation, the decrease in ACTH receptor expression between mid- and late gestation seems to occur primarily in the latter zone and may signal a selective decline in tropic responsivity of and delta5-C19- steroid, e.g. dehydroepiandrosterone, biosynthesis within the baboon fetal adrenal gland.
This article has been cited by other articles:
![]() |
A. Dumitrescu, G. W Aberdeen, G. J Pepe, and E. D Albrecht Developmental expression of cell cycle regulators in the baboon fetal adrenal gland J. Endocrinol., January 1, 2007; 192(1): 237 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Albrecht, G. W. Aberdeen, and G. J. Pepe Estrogen Elicits Cortical Zone-Specific Effects on Development of the Primate Fetal Adrenal Gland Endocrinology, April 1, 2005; 146(4): 1737 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bonenfant, C. H. Blomquist, P. R. Provost, R. Drolet, P. DAscoli, and Y. Tremblay Tissue- and Site-Specific Gene Expression of Type 2 17{beta}-Hydroxysteroid Dehydrogenase: In Situ Hybridization and Specific Enzymatic Activity Studies in Human Placental Endothelial Cells of the Arterial System J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4841 - 4850. [Abstract] [Full Text] |
||||
![]() |
J. R.G. Challis, S. G. Matthews, W. Gibb, and S. J. Lye Endocrine and Paracrine Regulation of Birth at Term and Preterm Endocr. Rev., October 1, 2000; 21(5): 514 - 550. [Abstract] [Full Text] |
||||
![]() |
E. D. Albrecht, J. S. Babischkin, W. A. Davies, M. G. Leavitt, and G. J. Pepe Identification and Developmental Expression of the Estrogen Receptor {alpha} and {beta} in the Baboon Fetal Adrenal Gland Endocrinology, December 1, 1999; 140(12): 5953 - 5961. [Abstract] [Full Text] |
||||
![]() |
R. B. Billiar, M. G. Leavitt, P. Smith, E. D. Albrecht, and G. J. Pepe Functional Capacity of Fetal Zone Cells of the Baboon Fetal Adrenal Gland: A Major Source of {alpha}-Inhibin Biol Reprod, July 1, 1999; 61(1): 142 - 146. [Abstract] [Full Text] |
||||
![]() |
G. W. Aberdeen, M. G. Leavitt, G. J. Pepe, and E. D. Albrecht Effect of Maternal Betamethasone Administration at Midgestation on Baboon Fetal Adrenal Gland Development and Adrenocorticotropin Receptor Messenger Ribonucleic Acid Expression J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 976 - 982. [Abstract] [Full Text] |
||||
![]() |
M. G. Leavitt, G. W. Aberdeen, M. G. Burch, E. D. Albrecht, and G. J. Pepe Inhibition of Fetal Adrenal Adrenocorticotropin Receptor Messenger Ribonucleic Acid Expression by Betamethasone Administration to the Baboon Fetus in Late Gestation Endocrinology, July 1, 1997; 138(7): 2705 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mesiano and R. B. Jaffe Developmental and Functional Biology of the Primate Fetal Adrenal Cortex Endocr. Rev., June 1, 1997; 18(3): 378 - 403. [Abstract] [Full Text] |
||||
![]() |
G. W. Aberdeen, J. S. Babischkin, W. A. Davies, G. J. Pepe, and E. D. Albrecht Decline in Adrenocorticotropin Receptor Messenger Ribonucleic Acid Expression in the Baboon Fetal Adrenocortical Zone in the Second Half of Pregnancy Endocrinology, April 1, 1997; 138(4): 1634 - 1641. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |